Advanced search
Publication Cover
Acta Oncologica Volume 37, 1998 - Issue 7-8
Journal homepage
289
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Predictive Factors of Histological Response to Primary Chemotherapy in Ewing's Sarcoma

Gaetano Bacci From the Department of Musculoskeletal Oncology (G. Bacci, P. Picci, M. Mercuri, S. Ferrari, A. Longhi, M. Cesari, N. Baldini), Istituti Ortopedici Rizzoli, and the Departments of Pediatric Oncology (P. Rosito, A.F. Mancini), Radiation Oncology (E. Barbieri), Bologna University, Bologna, Italy
,
Piero Picci From the Department of Musculoskeletal Oncology (G. Bacci, P. Picci, M. Mercuri, S. Ferrari, A. Longhi, M. Cesari, N. Baldini), Istituti Ortopedici Rizzoli, and the Departments of Pediatric Oncology (P. Rosito, A.F. Mancini), Radiation Oncology (E. Barbieri), Bologna University, Bologna, Italy
,
Mario Mercuri From the Department of Musculoskeletal Oncology (G. Bacci, P. Picci, M. Mercuri, S. Ferrari, A. Longhi, M. Cesari, N. Baldini), Istituti Ortopedici Rizzoli, and the Departments of Pediatric Oncology (P. Rosito, A.F. Mancini), Radiation Oncology (E. Barbieri), Bologna University, Bologna, Italy
,
Stefano Ferrari From the Department of Musculoskeletal Oncology (G. Bacci, P. Picci, M. Mercuri, S. Ferrari, A. Longhi, M. Cesari, N. Baldini), Istituti Ortopedici Rizzoli, and the Departments of Pediatric Oncology (P. Rosito, A.F. Mancini), Radiation Oncology (E. Barbieri), Bologna University, Bologna, Italy
,
Alessandra Longhi From the Department of Musculoskeletal Oncology (G. Bacci, P. Picci, M. Mercuri, S. Ferrari, A. Longhi, M. Cesari, N. Baldini), Istituti Ortopedici Rizzoli, and the Departments of Pediatric Oncology (P. Rosito, A.F. Mancini), Radiation Oncology (E. Barbieri), Bologna University, Bologna, Italy
,
Marilena Cesari From the Department of Musculoskeletal Oncology (G. Bacci, P. Picci, M. Mercuri, S. Ferrari, A. Longhi, M. Cesari, N. Baldini), Istituti Ortopedici Rizzoli, and the Departments of Pediatric Oncology (P. Rosito, A.F. Mancini), Radiation Oncology (E. Barbieri), Bologna University, Bologna, Italy
,
Pasquale Rosito From the Department of Musculoskeletal Oncology (G. Bacci, P. Picci, M. Mercuri, S. Ferrari, A. Longhi, M. Cesari, N. Baldini), Istituti Ortopedici Rizzoli, and the Departments of Pediatric Oncology (P. Rosito, A.F. Mancini), Radiation Oncology (E. Barbieri), Bologna University, Bologna, Italy
,
Antonia F. Mancini From the Department of Musculoskeletal Oncology (G. Bacci, P. Picci, M. Mercuri, S. Ferrari, A. Longhi, M. Cesari, N. Baldini), Istituti Ortopedici Rizzoli, and the Departments of Pediatric Oncology (P. Rosito, A.F. Mancini), Radiation Oncology (E. Barbieri), Bologna University, Bologna, Italy
,
Enza Barbieri From the Department of Musculoskeletal Oncology (G. Bacci, P. Picci, M. Mercuri, S. Ferrari, A. Longhi, M. Cesari, N. Baldini), Istituti Ortopedici Rizzoli, and the Departments of Pediatric Oncology (P. Rosito, A.F. Mancini), Radiation Oncology (E. Barbieri), Bologna University, Bologna, Italy
&
Nicola Baldini From the Department of Musculoskeletal Oncology (G. Bacci, P. Picci, M. Mercuri, S. Ferrari, A. Longhi, M. Cesari, N. Baldini), Istituti Ortopedici Rizzoli, and the Departments of Pediatric Oncology (P. Rosito, A.F. Mancini), Radiation Oncology (E. Barbieri), Bologna University, Bologna, Italy
 show all
Pages 671-676 | Published online: 08 Jul 2009

References

  • Alvegfird TA, Solheim 0, /kkerman M, Berg NO. Ewing's sarcoma. A preliminary report from the Scandinavian Sar-coma Group. Acta Oncol 1989; 28 (Suppl 2): 59–64.
  • Bacci G, Picci P, Avella M, et al. Neoadjuvant chemother-apy for localized Ewing's sarcoma of bone: experience at the Istituto Ortopedico Rizzoli. Cancer J 1991; 4: 335–42.
  • Craft AW, Cotterill SBA, Imeson J. Improvement in survival for Ewing's sarcoma by substitution of ifosfamide for cy-clophosphamide. A UKCCSG/MRC Study. Am J Pediat Hematol Oncol 1993; 15: 31–5.
  • Dunst J, Jiirgens H, Sauer R, et al. Radiation therapy in Ewing's sarcoma: an update of the CESS-86 trial. Int .1- Rad Oncol Biol Phys 1995; 4: 919–30.
  • Elomaa I, Blomqvist C, Swter G, et al. Three-year results of the SSG IX protocol in Ewing's sarcoma. Acta Orthop Scand 1994; 65: 77–8.
  • Jiirgens H, Exner U, Gadner H, et al. Multidisciplinary treatment of primary Ewing's sarcoma of bone. Cancer 1988; 61: 23–32.
  • Oberlin O, Habrand JL, Zucker JM, et al. No benefit of ifofasfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Pediatric Oncology. J Clin Oncol 1992; 10: 1407–12.
  • Oberlin 0, Patte C, Demeocq F, et al. The response to initial chemotherapy as a prognostic factor in localized Ew-ing's sarcoma. Eur J Cancer Clin Oncol 1985; 21: 463–7.
  • Sailer SL, Harmon DC, Mankin HJ, et al. Ewing's sarcoma: surgical resection as prognostic factor. Int .1- Radiat Oncol Biol Phys 1988; 15: 43–52.
  • Sauer R, Jiirgens H, Burgers JMV, et al. Prognostic factors in the treatment of Ewing's sarcoma. Radiother Oncol 1987; 10: 101–10.
  • kkerman M. Tumour necrosis and prognosis in Ewing's sarcoma. Acta Orthop Scand 1997; 273 (Suppl): 130–2.
  • Ayala AG. Tumor necrosis in treated Ewing's sarcoma. Pre-sented at the 32nd Annual Conference: Optimizing Manage-ment of Primary Bone Tumors: An International Symposium Emphasizing the Multi-Disciplinary Approach. Houston, TX, November 25, 1988.
  • Delepine N, Delepine G, Comille H, et al. Prognostic factors in patients with localized Ewing's sarcoma: the effect on survival of actual received drug dose intensity and of histo-logic response to chemotherapy. J Chemotherapy 1997; 9: 352–63.
  • Picci P, Bohling T, Bacci G, et al. Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol 1997; 15: 1553–9.
  • Jfirgens HF. Ewing's sarcoma and peripheral primitive neu-roectodermal tumor. Curr Opin Oncol 1994; 6: 391–6.
  • Gobel U, Jfirgens H, Etspuler G, et al. The prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents. J Cancer Res Clin Oncol 1987; 113: 187–93.
  • Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of muscoloskeletal sarcoma. Clin Orthop 1980; 153: 116–20.
  • Jfirgens H, Exner U, Kuhl J, et al. High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma. Cancer Chemother Pharmacol 1989; 24 (Suppl 1): S40—S44.
  • Magrath IT, Sandlund JT, et al. A phase II study of ifos-famide in the treatment of recurrent sarcomas in pediatric tumors. Contr Oncol 1987; 26: 114–24.
  • Miser JS, Kinsella TJ, Triche TJ, et al. Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treat-ment of recurrent sarcomas and other tumors of children and young adults. J Clin Oncol 1987; 5: 1191–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.